Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of a Fixed-Dose Combination Pill of Sofosbuvir and Daclatasvir in Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus

NCT03369327 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.

NCT NCT03369327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03369327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of a Fixed-Dose Combination Pill of Sofosbuvir and Daclatasvir in Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus
Lead sponsor
Tehran University of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2017
Completion date
December 1, 2018
Enrollment
232 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus infection, response to therapy of, human immunodeficiency virus